“Regenerative medicine” is about how cells, factors, proteins, tissues and other basic elements of the body work together to promote health, function and longevity. Regen Med is about how hospitals, scientists, individual clinicians, medical societies, payors and regulators collaborate to exploit for the benefit of patients — in an evidence-basedmanner — this broad, exciting field.At the core of Regen Med’s mission are two, mutually-supporting pillars: inCytes™ and Human/Cell Tissue Centers. These provide the foundation for cost-efficient delivery of evidence-based, regulatorily compliant regenerative medicine procedures (whether primary or adjunct). That same foundation also supports studies, trials, product incubation, value-based medicine, improved patient experience, professional education and clinical growth. Finally, this foundation enables deep, ongoing and professionally-rewarding collaboration among Regen Med Network members around the world.”

Biotechnology

Health Care

Life Sciences

Medical Devices

RegenMed

Michael Tierney

M. D.

Nicolas Tierney

Peter Johnson

The Research and Development team at RegenMed is dedicated to advancing the field of regenerative medicine through innovative studies and trials. By collaborating closely with hospital systems and the Regen Med Network, the team focuses on enhancing evidence-based practices and developing cutting-edge products. Their efforts aim to improve patient outcomes and support the cost-efficient delivery of regenerative therapies via the inCytes™ platform and Human/Cell Tissue Centers.

Research and Development

Leadership Team

��

Research and Development

About

Team members

��������

Research and Development

About

Team members

��